Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.
Nu Skin Enterprises Inc (NYSE: NUS) provides a centralized hub for tracking corporate developments across its global health, beauty, and wellness operations. This resource aggregates official press releases and verified news updates related to product innovations, financial performance, and strategic initiatives.
Investors and stakeholders gain immediate access to essential updates including quarterly earnings disclosures, manufacturing advancements through subsidiaries like Groviv and Wasatch Labs, and expansions of the company’s direct-selling network. All content is curated to support informed analysis of Nu Skin’s market position in the beauty and nutraceutical sectors.
The news collection features developments across three key areas: product launches in skincare and nutritional supplements, sustainability initiatives in automated agriculture technology, and financial disclosures reflecting global operations in 50+ countries. Additional coverage includes leadership updates and partnership announcements with digital platforms like Mavely.
Bookmark this page for streamlined monitoring of Nu Skin’s progress in merging scientific research with direct-selling expertise. Regular updates ensure timely awareness of material developments affecting the company’s NYSE-listed performance.
NU Skin Enterprises (NYSE:NUS) received coverage initiation from Stonegate Capital Partners following strong Q2 2025 performance. The company reported revenue of $386.1M, reaching the high end of their guidance range of $355.0M-$390.0M.
Key highlights include adjusted EPS of $0.43, significantly exceeding guidance of $0.20-$0.30, and adjusted net income growth of 103.5% year-over-year. The company's gross margin expanded 106 basis points quarter-over-quarter to 68.8%. Notable segment performance included Rhyz Manufacturing's 17% revenue growth and Latin America's 107% revenue increase year-over-year.
Nu Skin Enterprises (NYSE:NUS) reported Q2 2025 financial results with revenue of $386.1 million, at the high end of guidance despite a 12.1% year-over-year decline. The company achieved earnings per share of $0.43, exceeding forecasts and improving from $(2.38) in the prior year.
Key highlights include an 8% operating margin and strong performance in the Rhyz Manufacturing segment with 17% year-over-year growth. The company reached a positive net cash position for the first time in over 4 years. Nu Skin narrowed its 2025 revenue guidance to $1.48-$1.55 billion and raised EPS guidance to $3.05-$3.25.
Strategic initiatives include the upcoming Q4 preview of Prysm iO intelligent wellness device and planned expansion into India in 2026, building on success in Latin America where revenue grew 107% year-over-year.
Nu Skin Enterprises (NYSE:NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on September 10, 2025, to shareholders of record as of August 29, 2025.
Nu Skin Enterprises (NYSE:NUS) has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close. The company's management team will host a conference call with investors at 5 p.m. ET on the same day to discuss quarterly results and upcoming business initiatives.
The conference call webcast and financial information will be accessible through Nu Skin's investor relations website at ir.nuskin.com. A replay of the webcast will remain available until Thursday, August 21.
Nu Skin (NYSE: NUS) has announced a significant relaunch of its ageLOC® Tru Face® skincare line, focusing on sustainable packaging innovations while maintaining product efficacy. The initiative aims to save 515,000 pounds of glass and plastic and eliminate 572 tons of emissions annually by the end of 2025.
The refreshed line includes notable products such as the Transforming Gel Cream, showing 100% user satisfaction in hydration within two weeks, and the Refining Toner with up to 47% improvement in tone evenness. Key sustainability features include refillable systems, recycled materials usage, and innovative packaging solutions like the TFEU refill pouch that reduces material use by 96.8%.
Nu Skin Enterprises (NYSE: NUS) has announced that its board of directors has declared a quarterly cash dividend of $0.06 per share. The dividend will be paid on June 11, 2025, to shareholders who are on record as of May 30, 2025. This dividend declaration represents the company's continued commitment to returning value to shareholders through regular dividend payments.
Nu Skin Enterprises (NYSE: NUS) has scheduled the release of its first quarter 2025 financial results after market close on Thursday, May 8. The company's management team will host a conference call with investors at 5 p.m. ET on the same day to discuss quarterly performance and upcoming business initiatives.
The financial presentation and conference call will be accessible via webcast on the company's investor relations website at ir.nuskin.com. A replay option will remain available through Thursday, May 22.
Nu Skin Enterprises (NYSE: NUS) reported Q4 2024 revenue of $445.6 million, down 8.8% year-over-year but above company guidance, with a 4.1% FX impact. Q4 EPS was $(0.73), or $0.38 excluding restructuring charges. Full-year 2024 revenue reached $1.73 billion, declining 12% with a 3.8% FX impact.
The company's Rhyz segment showed strong growth, with Q4 revenue of $83.1 million (+27.7%) and full-year revenue of $286.6 million (+32.3%). Customer base decreased 15% to 831,972, with paid affiliates down 13% and sales leaders declining 16%.
For 2025, Nu Skin projects revenue between $1.48-$1.62 billion, expecting a 3% FX headwind. Q1 2025 revenue guidance is $345-365 million, with EPS forecast of $2.65-$2.75, or $0.10-$0.20 excluding the Mavely transaction gain.